Cargando…

Corrigendum to “Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis”

Detalles Bibliográficos
Autores principales:	Nouraei, S., Amir Ali Akbari, S., Jorjani, M., Alavi Majd, H., Afrakhteh, M., Ghafoorian, A., Tafazzoli Harandi, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723969/ https://www.ncbi.nlm.nih.gov/pubmed/29279857 http://dx.doi.org/10.1155/2017/9375678

Ejemplares similares

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis
por: Nouraei, S., et al.
Publicado: (2012)

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
por: Nyirjesy, Paul, et al.
Publicado: (2021)

Comparative evaluation of fluconazole and clotrimazole in treatment of oral candidiasis
por: Madane, Pragati C, et al.
Publicado: (2022)

Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women
por: Vahedpoor, Zahra, et al.
Publicado: (2021)

Coadministration of Ginger Extract and Fluconazole Shows a Synergistic Effect in the Treatment of Drug-Resistant Vulvovaginal Candidiasis
por: Khan, Arif, et al.
Publicado: (2021)

Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial
por: Mollazadeh-Narestan, Zahra, et al.
Publicado: (2022)

Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis
por: Khosravi Rad, K, et al.
Publicado: (2016)

Bioadhesive Films Containing Fluconazole for Mucocutaneous Candidiasis
por: Patel, S. K., et al.
Publicado: (2015)

In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis
por: Sobel, Jack D., et al.
Publicado: (2021)

Comparative Study of the Effectiveness of Oral Fluconazole and Intravaginal Clotrimazole in the Treatment of Vaginal Candidiasis
por: Mikamo, Hiroshige, et al.
Publicado: (1995)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
por: Golestannejad, Zahra, et al.
Publicado: (2022)

Preparation and Characterisation of Fluconazole Vaginal Films for the Treatment of Vaginal Candidiasis
por: Kumar, L., et al.
Publicado: (2013)

Assessment of Effectiveness of Fluconazole and Clotrimazole in Treating Oral Candidiasis Patients: A Comparative Study
por: Reddy, R. C. Jagat, et al.
Publicado: (2017)

Kangbainian Lotion Ameliorates Vulvovaginal Candidiasis in Mice by Inhibiting the Growth of Fluconazole-Resistant Candida albicans and the Dectin-1 Signaling Pathway Activation
por: Chen, Zewei, et al.
Publicado: (2022)

Fluconazole prophylaxis for prevention of invasive candidiasis in extremely preterm infants
por: Kim, Chun Soo
Publicado: (2020)

107. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules versus Fluconazole and Placebo in the Treatment of Acute Vulvovaginal Candidiasis Episodes in Subjects with Recurrent Vulvovaginal Candidiasis (ultraViolet)
por: Martens, Mark G, et al.
Publicado: (2021)

Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
por: Vuichard, Danielle, et al.
Publicado: (2014)

Sphingolipid Inhibitors as an Alternative to Treat Candidiasis Caused by Fluconazole-Resistant Strains
por: Rollin-Pinheiro, Rodrigo, et al.
Publicado: (2021)

Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis
por: Rençber, Seda, et al.
Publicado: (2016)

Fluconazole (Diflucan®)
por: Hollier, Lisa M., et al.
Publicado: (1995)

Efficacy of a medical grade honey formulation (L-Mesitran) in comparison with fluconazole in the treatment of women with recurrent vulvovaginal candidiasis: protocol for a randomised controlled trial (HONEY STUDY)
por: van Riel, Senna J J M, et al.
Publicado: (2023)

Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
por: Moreno-García, E, et al.
Publicado: (2022)

The effect of fluconazole treatment on tumor necrosis factor-alpha production in murine candidiasis.
por: Kalkanci, Ayse, et al.
Publicado: (2002)

Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile
por: Neufeld, Paulo Murillo, et al.
Publicado: (2015)

Antifungal Activity of ZnO Nanoparticles and Nystatin and Downregulation of SAP1-3 Genes Expression in Fluconazole-Resistant Candida albicans Isolates from Vulvovaginal Candidiasis
por: Hosseini, Seyededeh Sedigheh, et al.
Publicado: (2020)

Fluconazole Resistance and Virulence in In Vitro Induced-Fluconazole Resistant Strains and in Clinical Fluconazole Resistant Strain of Cryptococcus deuterogattii
por: Bertout, Sébastien, et al.
Publicado: (2023)

A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis
por: Nairy, Harish M, et al.
Publicado: (2011)

Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis
por: Gonzalez, Javier M., et al.
Publicado: (2015)

Antimicrobial Photodynamic Therapy in Combination with Nystatin in the Treatment of Experimental Oral Candidiasis Induced by Candida albicans Resistant to Fluconazole
por: Janeth Rimachi Hidalgo, Karem, et al.
Publicado: (2019)

The relationship between the use of fluconazole & the incidence of fluconazole-resistant Candida species
por: Kuo, Chia-Chang, et al.
Publicado: (2014)

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
por: Gebretekle, Gebremedhin Beedemariam, et al.
Publicado: (2022)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
por: Seidman, Larry S, et al.
Publicado: (2005)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

Candidiasis vulvovaginal tratamiento oral con itraconazol/
por: Rodriguez Serrano, Tiburcio Manuel
Publicado: (1993)

The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans
por: Li, Liping, et al.
Publicado: (2019)

In-Vitro Activity of Nano Fluconazole and Conventional Fluconazole against Clinically Important Dermatophytes
por: MUSAVI BAFRUI, Najmossadat, et al.
Publicado: (2020)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Correction to: El-Housiny et al., Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6vcss94c1s07bh56hln5k1kjlj